Lataa...
Hepatic de novo lipogenesis is suppressed and fat oxidation is increased by omega-3 fatty acids at the expense of glucose metabolism
OBJECTIVE: Increased hepatic de novo lipogenesis (DNL) is suggested to be an underlying cause in the development of nonalcoholic fatty liver disease and/or insulin resistance. It is suggested that omega-3 fatty acids (FA) lower hepatic DNL. We investigated the effects of omega-3 FA supplementation o...
Tallennettuna:
| Julkaisussa: | BMJ Open Diabetes Res Care |
|---|---|
| Päätekijät: | , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BMJ Publishing Group
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7078804/ https://ncbi.nlm.nih.gov/pubmed/32188593 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjdrc-2019-000871 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|